Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06274918 · ClinicalTrials.gov registry record
Reducing ESKAPE Transmission in the Operating Room
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 39
- Enrollment target
NCT06274918: Completed study, sponsored by University of Iowa.
NCT06274918 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06274918 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
This study is designed to examine the impact of a personalized, body worn alcohol dispenser on the epidemiology of ESKAPE transmission in the anesthesia work area for patients undergoing surgery requiring general anesthesia.
Primary Outcome
Reduce the number of Enterococcus, Staphylococcus aureus, Pseudomonas, and other gram-negative (i.e., Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) transmission events
Interventions
- DEVICE Personalized Body-Worn Alcohol Dispenser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2024-12-12 |
What the finished NCT06274918 record still lists
NCT06274918 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Personalized Body-Worn Alcohol Dispenser is the first listed.
NCT06274918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06274918 about?
NCT06274918 is a clinical study titled "Reducing ESKAPE Transmission in the Operating Room". This study is designed to examine the impact of a personalized, body worn alcohol dispenser on the epidemiology of ESKAPE transmission in the anesthesia work area for patients undergoing surgery requiring general anesthesia.
What is the current status of trial NCT06274918?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2023-02-01. Estimated completion is 2024-12-12.
What interventions are being tested in trial NCT06274918?
The interventions under investigation include: Personalized Body-Worn Alcohol Dispenser (DEVICE).
Who is sponsoring clinical trial NCT06274918?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI